Toggle navigation
Home
Search
Services
Blog
Contact
About
Laser Excited Flourescence Detection System for Cancer
Baldridge, John
Lasermed Corporation, Costa Mesa, CA, United States
Search 4 grants from John Baldridge
Search grants from Lasermed Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Determining astrocytic contributions to memory-related dimensions of PTSD
Development of Novel Agents Active against Hepatitis B Virus
Tumor-mediated impairment of IL-12 gene expression
Substance Abuse Treatment in Criminal Justice Settings
Mapping the Development of Inhibitory Mechanisms
Recently added grants:
Developing a set of robust tools to interrogate Legionella effector function
Pathogenic role of peroxisome proliferator-activated receptor alpha in periodontitis
Electroconvulsive therapy amplitude titration for improved clinical outcomes in late-life depression
Multi-atlas and whole body radiomics approaches for image-guided treatment of gynecologic cancers
A pilot study to define maintained alterations in mitochondrial DNA of eosinophilic esophagitis patients that may be exploited clinically
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CM057809-001
Application #
3613424
Study Section
Project Start
1985-09-30
Project End
Budget Start
1986-11-04
Budget End
1986-03-29
Support Year
Fiscal Year
1987
Total Cost
Indirect Cost
Institution
Name
Lasermed Corporation
Department
Type
DUNS #
City
Costa Mesa
State
CA
Country
United States
Zip Code
92626
Related projects
NIH 1987
N43 CM
Laser Excited Flourescence Detection System for Cancer
Baldridge, John / Lasermed Corporation
NIH 1985
N43 CM
Laser Excited Flourescence Detection System for Cancer
Baldridge, John / Lasermed Corporation
Comments
Be the first to comment on John Baldridge's grant